Pure Global AI
NCT06356077Not yet recruiting

Evaluation of the Satisfaction of a Hypertensive Population in Their Use of the Aktiia 24/7 Blood Pressure Monitor

OBPM_HTN2024 Study Evaluation of the Satisfaction of a Hypertensive Population in Their Use of the Aktiia 24/7 Optical Blood Pressure Monitoring (OBPM) Device: a Prospective Observational Clinical Study Across the United States
Aktiia SAClinicalTrials.gov
Verified
Study focus
Disease/Condition
Hypertension
Study type
Observational
Sponsor & location
Primary sponsor
Aktiia SA
Timeline & enrollment
Phase
N/A
Start date
Jul 15, 2024
End date
Dec 01, 2027
Enrollment
5000 participants
Primary outcome

Preferences of subjects regarding the method to monitor their blood pressure between Aktiia Bracelet, Home Blood Pressure Monitor, or Ambulatory Blood Pressure Monitor,Frequency of Aktiia app use,Frequency of use of Aktiia device as compared to previously use other blood pressure monitors

Summary

OBPM_HTN2024 study was designed by AKTIIA SA to evaluate how a hypertensive population,
 reflective of the United States and encompassing a range of phenotypes, perceives the Aktiia
 24/7 device (Aktiia G1) during their first 3 months of use.

ICD-10 classifications
Hypertensive diseasesRenovascular hypertensionSecondary hypertensionOther secondary hypertensionHypertensive heart disease
Data source
Registry
ClinicalTrials.gov
Trial ID
NCT06356077
Type
Non-Device Trial
About this record

Access comprehensive clinical trial information for NCT06356077 through Pure Global AI's free database. This phase not specified trial is sponsored by Aktiia SA and is currently Not yet recruiting. The study focuses on Hypertension. Target enrollment is 5000 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.